Invesco’s ALX Oncology ALXO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-73,836
| Closed | -$46K | – | 3765 |
|
2025
Q1 | $46K | Buy |
+73,836
| New | +$46K | ﹤0.01% | 3691 |
|
2024
Q3 | – | Sell |
-10,290
| Closed | -$62K | – | 3741 |
|
2024
Q2 | $62K | Buy |
+10,290
| New | +$62K | ﹤0.01% | 3786 |
|
2024
Q1 | – | Sell |
-385,232
| Closed | -$5.74M | – | 3849 |
|
2023
Q4 | $5.74M | Buy |
+385,232
| New | +$5.74M | ﹤0.01% | 2165 |
|
2022
Q2 | – | Sell |
-643,487
| Closed | -$10.9M | – | 4006 |
|
2022
Q1 | $10.9M | Buy |
643,487
+13,565
| +2% | +$229K | ﹤0.01% | 1913 |
|
2021
Q4 | $13.5M | Buy |
629,922
+115,107
| +22% | +$2.47M | ﹤0.01% | 1814 |
|
2021
Q3 | $38M | Buy |
514,815
+507,399
| +6,842% | +$37.5M | 0.01% | 1167 |
|
2021
Q2 | $406K | Buy |
7,416
+4,225
| +132% | +$231K | ﹤0.01% | 3479 |
|
2021
Q1 | $235K | Buy |
+3,191
| New | +$235K | ﹤0.01% | 3620 |
|